ReviewFrontiers in microbiology2026

From dysbiosis to tumorigenesis: microbiome-derived metabolites as emerging cancer biomarkers.

Anbalagan Sanjana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.